ritonavir and Pneumococcal-Infections

ritonavir has been researched along with Pneumococcal-Infections* in 1 studies

Trials

1 trial(s) available for ritonavir and Pneumococcal-Infections

Article	Year
Protease Inhibitors Do Not Affect Antibody Responses to Pneumococcal Vaccination. Clinical and vaccine immunology : CVI, 2016, Volume: 23, Issue:6 HIV(+) subjects on optimal antiretroviral therapy have persistently impaired antibody responses to pneumococcal vaccination. We explored the possibility that this effect may be due to HIV protease inhibitors (PIs). We found that in humans and mice, PIs do not affect antibody production in response to pneumococcal vaccination. Topics: Animals; Antibodies, Bacterial; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; HIV Protease Inhibitors; Humans; Immunoglobulin G; Immunoglobulin M; Male; Mice; Pneumococcal Infections; Pneumococcal Vaccines; Ritonavir; Streptococcus pneumoniae; Vaccination	2016

Article

Year

Protease Inhibitors Do Not Affect Antibody Responses to Pneumococcal Vaccination.

Clinical and vaccine immunology : CVI, 2016, Volume: 23, Issue:6

HIV(+) subjects on optimal antiretroviral therapy have persistently impaired antibody responses to pneumococcal vaccination. We explored the possibility that this effect may be due to HIV protease inhibitors (PIs). We found that in humans and mice, PIs do not affect antibody production in response to pneumococcal vaccination.

Topics: Animals; Antibodies, Bacterial; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; HIV Protease Inhibitors; Humans; Immunoglobulin G; Immunoglobulin M; Male; Mice; Pneumococcal Infections; Pneumococcal Vaccines; Ritonavir; Streptococcus pneumoniae; Vaccination

2016